1 |
Weiler JM, Gellhaus MA, Carter JG, et al. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery. J Allergy Clin Immunol 1990;85:713-9.
DOI
|
2 |
Levy JH, Zaidan JR, Faraj B. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes. Anesth Analg 1986;65:739-42.
|
3 |
Kimmel SE, Sekeres M, Berlin JA, Ellison N. Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass. Anesth Analg 2002;94:1402-8.
|
4 |
Porsche R, Brenner ZR. Allergy to protamine sulfate. Heart Lung 1999;28:418-28.
DOI
|
5 |
Horrow JC. Protamine: a review of its toxicity. Anesth Analg 1985;64:348-61.
|
6 |
McEvoy G. American hospital formulary service. Bethesda (MD): American Society of Hospital Pharmacists; 1998.
|
7 |
Viaro F, Dalio MB, Evora PR. Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: should methylene blue be the treatment of choice? Chest 2002;122:1061-6.
DOI
|
8 |
Panos A, Orrit X, Chevalley C, Kalangos A. Dramatic postcardiotomy outcome, due to severe anaphylactic reaction to protamine. Eur J Cardiothorac Surg 2003;24:325-7.
DOI
|